Patents by Inventor Arunkumar YADAV

Arunkumar YADAV has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250019410
    Abstract: The present invention relates to tirzepatide or a pharmaceutically acceptable salt thereof. The present invention also relates to a process for the preparation of tirzepatide or pharmaceutically acceptable salt thereof. The present invention also relates to novel fragments as intermediates and use thereof in the preparation of tirzepatide.
    Type: Application
    Filed: November 22, 2022
    Publication date: January 16, 2025
    Inventors: Arunkumar YADAV, Kunal PANDYA, Bhavna TAILOR, Brijesh PATEL, Jigar JOSHI, Vipulkumar PATEL, Mohan PRASAD
  • Publication number: 20220153802
    Abstract: The present invention relates to a stable parenteral dosage form with a ready-to-inject sterile stable aqueous solution of cetrorelix acetate. The invention also relates to an injection device prefilled with the ready-to-inject sterile stable aqueous solution of cetrorelix acetate. The present invention relates a method of inhibiting premature luteinizing hormone surges in women undergoing controlled ovarian stimulation comprising a stable parenteral dosage form with a ready-to-inject sterile stable aqueous solution of cetrorelix acetate.
    Type: Application
    Filed: October 23, 2020
    Publication date: May 19, 2022
    Inventors: Jaydip Joshi, Rakesh Thummar, Sudeep Agrawal, Subhas Balaram, Arunkumar Yadav, Rajamannar Thennati
  • Publication number: 20210121517
    Abstract: The present invention relates to a stable parenteral dosage form with a ready-to-inject sterile stable aqueous solution of Cetrorelix acetate. The invention also relates to an injection device prefilled with the ready-to-inject sterile stable aqueous solution of Cetrorelix acetate. The present invention relates a method of inhibiting premature luteinizing hormone surges in women undergoing controlled ovarian stimulation comprising a stable parenteral dosage form with a ready-to-inject sterile stable aqueous solution of Cetrorelix acetate.
    Type: Application
    Filed: March 10, 2020
    Publication date: April 29, 2021
    Inventors: Jaydip JOSHI, Rakesh THUMMAR, Sudeep AGRAWAL, Subhas Balaram BHOWMICK, Arunkumar YADAV, Rajamannar THENNATI